The prices of cells have decreased for the fourth week in a row, according to OPIS data. Due to the acute lack of downstream demand, cell makers have been engaged in a price war; they have to compete to cut prices in order to encourage demand and increase sales volume, according to a cell manufacturer.
So is this good or bad? Lower prices are always better imo, but it's concerning that there isn't enough demand to match the supply.